These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 12150690

  • 1. Babesiosis in humans: a treatment review.
    Weiss LM.
    Expert Opin Pharmacother; 2002 Aug; 3(8):1109-15. PubMed ID: 12150690
    [Abstract] [Full Text] [Related]

  • 2. Atovaquone and azithromycin for the treatment of babesiosis.
    Krause PJ, Lepore T, Sikand VK, Gadbaw J, Burke G, Telford SR, Brassard P, Pearl D, Azlanzadeh J, Christianson D, McGrath D, Spielman A.
    N Engl J Med; 2000 Nov 16; 343(20):1454-8. PubMed ID: 11078770
    [Abstract] [Full Text] [Related]

  • 3. Atovaquone in the treatment of Babesia microti infections in hamsters.
    Wittner M, Lederman J, Tanowitz HB, Rosenbaum GS, Weiss LM.
    Am J Trop Med Hyg; 1996 Aug 16; 55(2):219-22. PubMed ID: 8780464
    [Abstract] [Full Text] [Related]

  • 4. Combination of Clofazimine and Atovaquone as a Potent Therapeutic Regimen for the Radical Cure of Babesia microti Infection in Immunocompromised Hosts.
    Tuvshintulga B, Sivakumar T, Nugraha AB, Ahedor B, Batmagnai E, Otgonsuren D, Liu M, Xuan X, Igarashi I, Yokoyama N.
    J Infect Dis; 2022 Jan 18; 225(2):238-242. PubMed ID: 34664651
    [Abstract] [Full Text] [Related]

  • 5. Emergence of resistance to azithromycin-atovaquone in immunocompromised patients with Babesia microti infection.
    Wormser GP, Prasad A, Neuhaus E, Joshi S, Nowakowski J, Nelson J, Mittleman A, Aguero-Rosenfeld M, Topal J, Krause PJ.
    Clin Infect Dis; 2010 Feb 01; 50(3):381-6. PubMed ID: 20047477
    [Abstract] [Full Text] [Related]

  • 6. Efficacy, safety and tolerance of imidocarb dipropionate versus atovaquone or buparvaquone plus azithromycin used to treat sick dogs naturally infected with the Babesia microti-like piroplasm.
    Checa R, Montoya A, Ortega N, González-Fraga JL, Bartolomé A, Gálvez R, Marino V, Miró G.
    Parasit Vectors; 2017 Mar 13; 10(1):145. PubMed ID: 28292316
    [Abstract] [Full Text] [Related]

  • 7. The treatment of babesiosis.
    Ranque S.
    N Engl J Med; 2001 Mar 08; 344(10):773-4. PubMed ID: 11236790
    [No Abstract] [Full Text] [Related]

  • 8. Atovaquone and azithromycin treatment for babesiosis in an infant.
    Raju M, Salazar JC, Leopold H, Krause PJ.
    Pediatr Infect Dis J; 2007 Feb 08; 26(2):181-3. PubMed ID: 17259886
    [Abstract] [Full Text] [Related]

  • 9. Human Babesiosis.
    Waked R, Krause PJ.
    Infect Dis Clin North Am; 2022 Sep 08; 36(3):655-670. PubMed ID: 36116841
    [Abstract] [Full Text] [Related]

  • 10. Treatment of refractory Babesia microti infection with atovaquone-proguanil in an HIV-infected patient: case report.
    Vyas JM, Telford SR, Robbins GK.
    Clin Infect Dis; 2007 Dec 15; 45(12):1588-90. PubMed ID: 18190320
    [Abstract] [Full Text] [Related]

  • 11. Misdiagnosis of Babesiosis as Malaria, Equatorial Guinea, 2014.
    Arsuaga M, González LM, Padial ES, Dinkessa AW, Sevilla E, Trigo E, Puente S, Gray J, Montero E.
    Emerg Infect Dis; 2018 Aug 15; 24(8):1588-1589. PubMed ID: 30016247
    [Abstract] [Full Text] [Related]

  • 12. Atovaquone plus cholestyramine in patients coinfected with Babesia microti and Borrelia burgdorferi refractory to other treatment.
    Shoemaker RC, Hudnell HK, House DE, Van Kempen A, Pakes GE, COL40155 Study Team.
    Adv Ther; 2006 Aug 15; 23(1):1-11. PubMed ID: 16644602
    [Abstract] [Full Text] [Related]

  • 13. Transfusion-transmitted babesiosis in an immunocompromised patient: a case report and review.
    Wudhikarn K, Perry EH, Kemperman M, Jensen KA, Kline SE.
    Am J Med; 2011 Sep 15; 124(9):800-5. PubMed ID: 21683324
    [Abstract] [Full Text] [Related]

  • 14. Babesiosis in Long Island: review of 62 cases focusing on treatment with azithromycin and atovaquone.
    Kletsova EA, Spitzer ED, Fries BC, Marcos LA.
    Ann Clin Microbiol Antimicrob; 2017 Apr 11; 16(1):26. PubMed ID: 28399851
    [Abstract] [Full Text] [Related]

  • 15. Clinical and Molecular Evidence of Atovaquone and Azithromycin Resistance in Relapsed Babesia microti Infection Associated With Rituximab and Chronic Lymphocytic Leukemia.
    Simon MS, Westblade LF, Dziedziech A, Visone JE, Furman RR, Jenkins SG, Schuetz AN, Kirkman LA.
    Clin Infect Dis; 2017 Oct 01; 65(7):1222-1225. PubMed ID: 28541469
    [Abstract] [Full Text] [Related]

  • 16. Activity of atovaquone against Babesia microti in the Mongolian gerbil, Meriones unguiculatus.
    Gray JS, Pudney M.
    J Parasitol; 1999 Aug 01; 85(4):723-8. PubMed ID: 10461956
    [Abstract] [Full Text] [Related]

  • 17. The treatment of babesiosis.
    Weiss LM, Wittner M, Tanowitz HB.
    N Engl J Med; 2001 Mar 08; 344(10):773. PubMed ID: 11236789
    [No Abstract] [Full Text] [Related]

  • 18. Diagnosis of a tick-borne coinfection in a patient with persistent symptoms following treatment for Lyme disease.
    Hoversten K, Bartlett MA.
    BMJ Case Rep; 2018 Sep 27; 2018():. PubMed ID: 30262525
    [Abstract] [Full Text] [Related]

  • 19. Variable clinical presentations of babesiosis.
    Paparone P, Paparone PW.
    Nurse Pract; 2018 Oct 27; 43(10):48-54. PubMed ID: 30234826
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.